🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📑 Multidisciplinary care for patients with #HCC is associated w ⬇️ mortality! ⭐️Increasingly important given the complexity of treatment decisions! #LiverTwitter #OncTwitter #RadsTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

RCT: Among participants using CBD at a dosage representative of consumer products, 5.6% experienced liver enzyme elevations. ja.ma/3Iebkrc

A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results and Research Summary:

In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial results and Research Summary: nej.md/44ZeMPz

💊Oral contraceptive use and risk of HCC or intrahepatic CCA The Lancet Oncology ❌No clear association ❓Maybe a little increase with a use of long duration (>5years) 👉thelancet.com/journals/lanon… #cancer #oncology #liver #MedX OncoAlert Liver Cancer Connect Cholangiocarcinoma Foundation

New in Journal of Liver Cancer Expert survey on systemic therapy indications for #HCC in Korea: bridging clinical practice and reimbursement criteria doi.org/10.17998/jlc.2…

🏥Early mortality in atezo-beva for HCC JHEP Reports 🚨CPS B and high CRP ➡️ early mortality (90days) ❗️Among patients with CPS B: B9, ECOG ≥2, high creatinin 👉jhep-reports.eu/article/S2589-… #cancer #oncology #MedX #liver OncoAlert

Fulminant Tumour Lysis Syndrome after Nivolumab and Ipilimumab treatment for Hepatocellular Carcinoma Journal of Hepatology doi.org/10.1016/j.jhep… 🧐New problems with more effective systemic therapies in HCC❗️ ESMO - Eur. Oncology EASL Education ILCA

Discover how systemic inflammatory response markers enhance prognostic accuracy in hepatocellular carcinoma (HCC). This study presents important findings that improve current risk stratification models and support more precise clinical decision-making. 📖 Read the full article:

Adjuvant Chemoradiation & Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer JAMA Oncology doi.org/10.1001/jamaon… 🔎🇨🇳phs-2 trial 👉Camrelizumab > cape + RT vs obs. 👉3-year OS rate: 58.2 vs 30.5% 🧐Supports adj. Tx, ARTEMIDE-Biliary01 awaited ESMO - Eur. Oncology EASL Education

The use of a patient-facing health app for colorectal cancer screening was low and did not improve screening completion rates, regardless of the intensity of the implementation strategy. ja.ma/3GxfNok

📢 REVISIT #HCC Surveillance Series from Frontline Gastro A must-read for every #Hepatologist, #GI specialist & #CancerCare provider👇 🧵Key takeaways from 3 landmark papers: #LiverTwitter #MedTwitter #Cirrhosis #CancerScreening #Hepatology #Ultrasound #Oncology #BSG #NHS

Dark chocolate enhances cognitive function & releases nerve growth factors. 🧵1/9

Older patients and those with elevated alpha-fetoprotein levels or poorer liver function are at greatest risk of #HCC, highlighting an unmet need for better risk stratification models ➡️ ow.ly/uCYZ50WlTof

📝 New blog alert from Frontline Gastro! GLP-1s, tirzepatide & MASLD: A new frontier for gastroenterologists How should we respond to the rise of weight-loss pharmacotherapy in liver disease care? 📚 This blog explores: – Where GLP-1s fit in MASLD management – The shifting

Cheng Han Ng JAMA Network Open We also found the same in our multi-centre UK study!! Aetiology clearly plays an important role. More research needed 🔍 pubmed.ncbi.nlm.nih.gov/40337094/

Most viewed this week from JAMA Internal Medicine: Among participants using CBD at a dosage representative of consumer products, 5.6% experienced liver enzyme elevations. ja.ma/466WVqM

Surveillance improved survival rates in hepatocellular carcinoma (HCC) but was less consistent for metabolic and alcohol-associated HCC. ja.ma/3TusCml

Cardiovascular Risk Assessment Tools are Insufficient for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Barritt, et al. 📕 doi.org/10.14309/ajg.0…   sidbarritt4 Elliot Tapper Rohit Loomba Arun J. Sanyal Target RWE ✨💊🔬 Millie Long Jasmohan Bajaj

📋Environmental Risk Factors for Liver Cancer HEPATOLOGY Journal 👉journals.lww.com/hep/abstract/9… #cancer #oncology #liver #MedX OncoAlert